Highlights

[DPHARMA] YoY Quarter Result on 2014-03-31 [#1]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 20-May-2014
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2014
Quarter 31-Mar-2014  [#1]
Profit Trend QoQ -     -10.18%    YoY -     24.87%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 120,994 79,470 45,599 40,495 37,837 36,057 32,984 24.16%
  YoY % 52.25% 74.28% 12.60% 7.02% 4.94% 9.32% -
  Horiz. % 366.83% 240.93% 138.25% 122.77% 114.71% 109.32% 100.00%
PBT 11,176 9,941 12,198 11,175 8,956 8,869 7,875 6.00%
  YoY % 12.42% -18.50% 9.15% 24.78% 0.98% 12.62% -
  Horiz. % 141.92% 126.23% 154.90% 141.90% 113.73% 112.62% 100.00%
Tax -2,558 -2,113 -3,229 -2,810 -2,257 -2,161 -1,951 4.61%
  YoY % -21.06% 34.56% -14.91% -24.50% -4.44% -10.76% -
  Horiz. % 131.11% 108.30% 165.50% 144.03% 115.68% 110.76% 100.00%
NP 8,618 7,828 8,969 8,365 6,699 6,708 5,924 6.44%
  YoY % 10.09% -12.72% 7.22% 24.87% -0.13% 13.23% -
  Horiz. % 145.48% 132.14% 151.40% 141.21% 113.08% 113.23% 100.00%
NP to SH 8,618 7,843 8,969 8,365 6,699 6,708 5,924 6.44%
  YoY % 9.88% -12.55% 7.22% 24.87% -0.13% 13.23% -
  Horiz. % 145.48% 132.39% 151.40% 141.21% 113.08% 113.23% 100.00%
Tax Rate 22.89 % 21.26 % 26.47 % 25.15 % 25.20 % 24.37 % 24.77 % -1.31%
  YoY % 7.67% -19.68% 5.25% -0.20% 3.41% -1.61% -
  Horiz. % 92.41% 85.83% 106.86% 101.53% 101.74% 98.39% 100.00%
Total Cost 112,376 71,642 36,630 32,130 31,138 29,349 27,060 26.75%
  YoY % 56.86% 95.58% 14.01% 3.19% 6.10% 8.46% -
  Horiz. % 415.28% 264.75% 135.37% 118.74% 115.07% 108.46% 100.00%
Net Worth 463,071 457,492 205,045 190,050 176,143 170,824 162,320 19.07%
  YoY % 1.22% 123.12% 7.89% 7.90% 3.11% 5.24% -
  Horiz. % 285.28% 281.85% 126.32% 117.08% 108.52% 105.24% 100.00%
Dividend
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 463,071 457,492 205,045 190,050 176,143 170,824 162,320 19.07%
  YoY % 1.22% 123.12% 7.89% 7.90% 3.11% 5.24% -
  Horiz. % 285.28% 281.85% 126.32% 117.08% 108.52% 105.24% 100.00%
NOSH 278,959 278,959 139,486 138,723 138,695 138,881 138,735 12.33%
  YoY % 0.00% 99.99% 0.55% 0.02% -0.13% 0.11% -
  Horiz. % 201.07% 201.07% 100.54% 99.99% 99.97% 100.11% 100.00%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 7.12 % 9.85 % 19.67 % 20.66 % 17.70 % 18.60 % 17.96 % -14.28%
  YoY % -27.72% -49.92% -4.79% 16.72% -4.84% 3.56% -
  Horiz. % 39.64% 54.84% 109.52% 115.03% 98.55% 103.56% 100.00%
ROE 1.86 % 1.71 % 4.37 % 4.40 % 3.80 % 3.93 % 3.65 % -10.62%
  YoY % 8.77% -60.87% -0.68% 15.79% -3.31% 7.67% -
  Horiz. % 50.96% 46.85% 119.73% 120.55% 104.11% 107.67% 100.00%
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 43.37 28.49 32.69 29.19 27.28 25.96 23.77 10.53%
  YoY % 52.23% -12.85% 11.99% 7.00% 5.08% 9.21% -
  Horiz. % 182.46% 119.86% 137.53% 122.80% 114.77% 109.21% 100.00%
EPS 3.43 2.81 6.43 6.03 4.83 4.83 4.27 -3.58%
  YoY % 22.06% -56.30% 6.63% 24.84% 0.00% 13.11% -
  Horiz. % 80.33% 65.81% 150.59% 141.22% 113.11% 113.11% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 1.6600 1.6400 1.4700 1.3700 1.2700 1.2300 1.1700 6.00%
  YoY % 1.22% 11.56% 7.30% 7.87% 3.25% 5.13% -
  Horiz. % 141.88% 140.17% 125.64% 117.09% 108.55% 105.13% 100.00%
Adjusted Per Share Value based on latest NOSH - 706,330
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 17.13 11.25 6.46 5.73 5.36 5.10 4.67 24.16%
  YoY % 52.27% 74.15% 12.74% 6.90% 5.10% 9.21% -
  Horiz. % 366.81% 240.90% 138.33% 122.70% 114.78% 109.21% 100.00%
EPS 1.22 1.11 1.27 1.18 0.95 0.95 0.84 6.41%
  YoY % 9.91% -12.60% 7.63% 24.21% 0.00% 13.10% -
  Horiz. % 145.24% 132.14% 151.19% 140.48% 113.10% 113.10% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.6556 0.6477 0.2903 0.2691 0.2494 0.2418 0.2298 19.07%
  YoY % 1.22% 123.11% 7.88% 7.90% 3.14% 5.22% -
  Horiz. % 285.29% 281.85% 126.33% 117.10% 108.53% 105.22% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 2.3100 2.5500 3.8800 3.0300 2.2300 2.4000 2.3500 -
P/RPS 5.33 8.95 11.87 10.38 8.17 9.24 9.88 -9.77%
  YoY % -40.45% -24.60% 14.35% 27.05% -11.58% -6.48% -
  Horiz. % 53.95% 90.59% 120.14% 105.06% 82.69% 93.52% 100.00%
P/EPS 74.77 90.70 60.34 50.25 46.17 49.69 55.04 5.23%
  YoY % -17.56% 50.31% 20.08% 8.84% -7.08% -9.72% -
  Horiz. % 135.85% 164.79% 109.63% 91.30% 83.88% 90.28% 100.00%
EY 1.34 1.10 1.66 1.99 2.17 2.01 1.82 -4.97%
  YoY % 21.82% -33.73% -16.58% -8.29% 7.96% 10.44% -
  Horiz. % 73.63% 60.44% 91.21% 109.34% 119.23% 110.44% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.39 1.55 2.64 2.21 1.76 1.95 2.01 -5.96%
  YoY % -10.32% -41.29% 19.46% 25.57% -9.74% -2.99% -
  Horiz. % 69.15% 77.11% 131.34% 109.95% 87.56% 97.01% 100.00%
Price Multiplier on Announcement Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 22/05/17 18/05/16 18/05/15 20/05/14 27/05/13 17/05/12 25/05/11 -
Price 2.3200 2.4000 3.9000 3.0900 2.5100 2.3800 2.5700 -
P/RPS 5.35 8.42 11.93 10.59 9.20 9.17 10.81 -11.05%
  YoY % -36.46% -29.42% 12.65% 15.11% 0.33% -15.17% -
  Horiz. % 49.49% 77.89% 110.36% 97.96% 85.11% 84.83% 100.00%
P/EPS 75.10 85.36 60.65 51.24 51.97 49.28 60.19 3.75%
  YoY % -12.02% 40.74% 18.36% -1.40% 5.46% -18.13% -
  Horiz. % 124.77% 141.82% 100.76% 85.13% 86.34% 81.87% 100.00%
EY 1.33 1.17 1.65 1.95 1.92 2.03 1.66 -3.62%
  YoY % 13.68% -29.09% -15.38% 1.56% -5.42% 22.29% -
  Horiz. % 80.12% 70.48% 99.40% 117.47% 115.66% 122.29% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.40 1.46 2.65 2.26 1.98 1.93 2.20 -7.25%
  YoY % -4.11% -44.91% 17.26% 14.14% 2.59% -12.27% -
  Horiz. % 63.64% 66.36% 120.45% 102.73% 90.00% 87.73% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

572  344  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FINTEC 0.035+0.005 
 MMAG 0.185-0.005 
 VSOLAR 0.02+0.005 
 EURO 1.10-0.11 
 MTOUCHE 0.090.00 
 SERBADK 0.625-0.005 
 HHHCORP 0.190.00 
 MRDIY 3.900.00 
 FOCUS 0.04+0.005 
 EDARAN 1.17+0.265 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. What Professor Dennis Etler said about China - Koon Yew Yin Koon Yew Yin's Blog
2. Serba Dinamik rombak struktur Lembaga Pengarah, lantik IIlyas Pakeer sebagai pengerusi Oil and Gas Malaysia News
3. [MUST READ] Important message for all investors who are planning to invest in AT or existing AT shareholders Important message for all investors who are planning to invest in AT or existing AT shareholders
4. UNCOMMON ACTIVITIES SPOTTED ON RECENT CORPORATE EXERCISE OF THIS COMPANY!! Swim With Sharks
5. BREAKING: The Las Vegas Strip Is Back and May Be Better Than Ever [SEE INSIDE FOR TRIPLE DIGIT GAINS] A blog to publish and share information
6. 上升股:国家能源 阻力RM10.94 南洋行家论股
7. Singapore sees first day rush for Sinovac vaccine; as 16 Covid-19 cases announced on Friday (June 18) Good Articles to Share
8. Media - Attractive valuations as recovery prospects brighten AmInvest Research Reports
PARTNERS & BROKERS